SCHEMBL29778809

SCHEMBL29778809

C1=Nc2cccc3cccc(c23)N1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 1.00
GAA P10253 11/20 0.47
MAPT P10636 9/20 0.47
MCL1 Q07820 3/20 0.47
KMT2A Q03164 10/20 0.43
MEN1 O00255 9/20 0.43
LMNA P02545 4/20 0.43
KDM4E B2RXH2 3/20 0.43
USP2 O75604 2/20 0.43
APAF1 O14727 1/20 0.43
PLCG1 P19174 1/20 0.43
CCR6 P51684 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8112 1.00 GRK6 (1.00) GRK6GAAMAPTMCL1KMT2A
Hydrochloric Acid SCHEMBL11423019 0.98 GRK6 (0.96) GRK6GAAMAPTMCL1KMT2A
Bromide SCHEMBL31741343 0.98 GRK6 (0.96) GRK6GAAMAPTMCL1KMT2A
Formaldehyde SCHEMBL27694578 0.94 GRK6 (0.89) GRK6GAAMAPTMCL1KMT2A
Benzoquinone SCHEMBL28256504 0.89 GRK6 (0.80) GRK6GAAMAPTMCL1KMT2A
Acetic Acid SCHEMBL15018560 0.88 GRK6 (0.77) GRK6GAAMAPTMCL1KMT2A
SCHEMBL27746989 0.87 GRK6 (0.75) GRK6GAAMAPTMCL1KMT2A
SCHEMBL27475210 0.87 GRK6 (0.75) GRK6GAAMAPTMCL1KMT2A
Phenanthroline SCHEMBL23829939 0.85 GRK6 (0.73) GRK6GAAMAPTMCL1KMT2A
Phenoxazine SCHEMBL27858947 0.84 GRK6 (0.71) GRK6GAAMAPTMCL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115003302-A Orally administered combination of amoxicillin and avibactam derivatives for the treatment of mycobacterial infections ARIXA制药公司 2022-09-02 CN disclosed